Interestingly, mRNA expression of p47phox (NCF1), p67phox (NCF2), and gp91phox (NOX2) are up-regulated in samples from patients with resistance to imatinib as compared to blast crisis (BC) CML patients (Figure 1H). The gene discussed is NCF2; the disease is breast cancer.